GLP-1 and exendin-4 transiently enhance GABAA receptor-mediated synaptic and tonic currents in rat hippocampal CA3 pyramidal neurons
Clinical Update 11/08/2022 Liquid vs
The role of the gut microbiome in Alzheimers disease

Common Types of Modifications Fatty acid conjugation Used to extend half-life by enhancing albumin binding (common in long-acting GLP-1 analogs) Oxidation (e.g., Methionine oxidation) Can occur during manufacturing or storage, affecting stability Deamidation (Asparagine, Glutamine) Leads to structural changes that may alter biological activity Truncation or cleavage products Results from degradation, impacting peptide integrity Why Detecting Modifications Matters Affects bioavailability and efficacy Structural changes can alter receptor binding and therapeutic performance Critical for regulatory submissions Regulatory agencies require detailed characterization of all variants and impurities Ensures product stability Helps monitor degradation pathways during stability studies Supports biosimilarity assessments Essential for comparing innovator and generic GLP-1 products 8: Data Analysis and Interpretation Accurate data analysis and interpretation are essential in Peptide Sequencing of GLP-1 Peptide to ensure correct sequence assignment, reliable impurity identification, and confident characterization of structural modifications

As semaglutide is contraindicated in pregnancy, treatment was discontinued, and the patient was excluded from further analysis since she did not meet the inclusion criteria at baseline
Jest to fundament stabilnoci, na ktrym opieraj si kluczowe publikacje naukowe w The New England Journal of Medicine (NEJM) oraz The Lancet